Percutaneous Mechanical Circulatory Support Devices Market Report by Trends, Drivers, and Challenges - 2025

The global market for percutaneous mechanical circulatory support devices is projected to grow significantly, reaching approximately US$ 2,977.8 million by 2025, up from US$ 1,188.2 million in 2017. This growth represents a compound annual growth rate (CAGR) of 12.3% from 2018 to 2025.

Percutaneous mechanical circulatory support devices are primarily utilized as a temporary solution for patients experiencing cardiogenic shock and heart failure. These conditions are among the most prevalent cardiovascular diseases, which pose a substantial health burden worldwide.

According to the World Health Organization (WHO), cardiovascular diseases were the leading cause of mortality globally in 2017. The organization reported that in 2016, approximately 17.9 million individuals died from cardiovascular diseases. While metabolic disorders have been increasingly linked to cardiovascular disease (CVD), hypertension remains the predominant risk factor, particularly among the Japanese population.

A study conducted by the Japan Public Health Center in March 2017 established that cardiovascular disease is a significant risk factor for both stroke and heart failure, especially in older adults. In the United States, heart disease is the foremost cause of death across various ethnic groups, including African Americans, Hispanics, and Caucasians.

Data from the Centers for Disease Control and Prevention (CDC) indicates that in 2016, around 610,000 individuals succumbed to heart disease in the U.S., accounting for one in every four deaths. Furthermore, the Global Burden of Disease study from April 2016 revealed that India has a CVD death rate of 272 per 100,000 population, surpassing the global average of 235 per 100,000 population.

Research indicates that advancements and accumulated experience with percutaneous mechanical circulatory support devices may lead to improved patient outcomes. The rising incidence of cardiovascular diseases, particularly heart failure, is driving the demand for mechanical circulatory devices, which are emerging as viable treatment options for patients. This trend is expected to significantly enhance the growth of the percutaneous mechanical circulatory support devices market.

The global market for percutaneous mechanical circulatory support devices is categorized by product type, including intra-aortic balloon pumps, VA-extracorporeal membrane oxygenation (ECMO), and short-term ventricular assist devices. The short-term ventricular assist devices segment is anticipated to experience a CAGR of 12.7% during the forecast period. Intra-aortic balloon pumps are particularly promising for treating heart failure and cardiogenic shock, leading this segment to capture the largest market share of 42.0% within the percutaneous mechanical circulatory support devices market. This segment is expected to maintain its dominance in the upcoming years.

Key sources of information for the percutaneous mechanical circulatory support devices market report include reputable organizations such as the Heart Failure Society of America, World Health Organization, Centers for Disease Control and Prevention (CDC), the Department of Cardiovascular Surgery in Italy, the Food and Drug Administration (FDA), and the India Brand Equity Foundation (IBEF), among others.